This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Capella Bioscience Ltd., Centessa Pharmaceuticals (UK) Limited. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Steve Holmes - Innovator in Antigen Binding Molecules
Introduction
Steve Holmes is a notable inventor based in Altrincham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules. His work focuses on innovative solutions for treating inflammatory and immune disorders.
Latest Patents
Steve Holmes holds a patent for "Antigen binding molecules that bind LIGHT." This invention relates to antigen binding molecules, including antibodies, fragments, and variants that specifically bind to the TNF-related cytokine LIGHT (TNFSF14). The patent outlines methods for using these molecules in the treatment and prevention of various inflammatory and immune disorders.
Career Highlights
Steve is currently associated with Centessa Pharmaceuticals (UK) Limited, where he applies his expertise in biotechnology to advance therapeutic solutions. His work at Centessa Pharmaceuticals emphasizes the importance of innovative research in addressing complex health challenges.
Conclusion
Steve Holmes is a dedicated inventor whose work in antigen binding molecules has the potential to significantly impact the treatment of inflammatory and immune disorders. His contributions to the field exemplify the importance of innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile